dextrothyroxine has been researched along with clofibrate in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 57 (98.28) | 18.7374 |
1990's | 1 (1.72) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schettler, G | 2 |
Stamler, J; Wenger, NK | 1 |
Borhani, NO | 2 |
Vogelberg, KH | 1 |
Levy, RI | 3 |
Stamler, J | 2 |
Dorph, DJ; Smith, H; YĆ¼, TF | 1 |
Clopath, P; Dicato, MA | 1 |
Martz, BL | 1 |
Fleischmajer, R | 1 |
Augustin, J; Greten, H; Klose, G; Middelhoff, G; Mordasini, R | 1 |
Hansen, PF | 1 |
Frantz, ID | 1 |
Kritchevsky, D | 1 |
Ritland, S | 1 |
Caruzzo, C | 1 |
Sirtori, C | 1 |
Gotto, AM; Yeshurun, D | 1 |
Ritter, KS | 1 |
Blum, CB; Levy, RI | 1 |
Perry, RS | 1 |
Gotto, AM; Jones, PH; Scott, LW | 1 |
Berge, KG; Canner, PL; Friedewald, W; Friedman, L; Prineas, RJ; Stamler, J; Wenger, NK | 1 |
Parker, F | 1 |
Baggio, G; Baiocchi, MR; Briani, G; Crepaldi, G; Fellin, R | 1 |
Sellers, E; Weser, JK | 1 |
Klimov, AN; Nikul'cheva, NG | 1 |
Berkowitz, D | 2 |
Krikler, DM | 1 |
Buchwald, H; Moore, RB; Varco, RL | 1 |
Bagdade, JD | 1 |
Chait, A; Lewis, B | 1 |
Lees, RS; Wilson, DE | 1 |
Bhatia, ML; Roy, SB; Setty, KR | 1 |
Weiss, P | 1 |
Lewis, B | 1 |
Casdorph, HR | 1 |
Schade, RW | 1 |
Hunninghake, DB | 1 |
von Bock und Polach, U | 1 |
Kolb, S; Sailer, D | 1 |
Paredero Del Bosque Martin, V | 1 |
Furberg, CD; Gould, AL; Heyse, JF; Rossouw, JE; Santanello, NC | 1 |
STRISOWER, B; STRISOWER, EH | 1 |
17 review(s) available for dextrothyroxine and clofibrate
Article | Year |
---|---|
Primary prevention of coronary heart disease: a critique.
Topics: Adult; Blood Pressure; Cholesterol; Clofibrate; Coronary Disease; Dextrothyroxine; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Estrogens, Conjugated (USP); Fats, Unsaturated; Female; Glycine max; Humans; Male; Middle Aged; Myocardial Infarction; Nicotinic Acids; Oils; Psychology; Recurrence; Risk; Smoking; Vegetables; Zea mays | 1977 |
[Lipid-lowering drugs. Therapeutics and adverse effects].
Topics: Arteriosclerosis; Child; Cholelithiasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids; Phenoxyacetates; Sitosterols | 1979 |
The effect of hypolipidemic drugs on plasma lipoproteins.
Topics: Aminosalicylic Acid; Animals; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Dogs; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Neomycin; Nicotinic Acids; Rats; Sitosterols | 1977 |
Hyperlipidemia in primary gout.
Topics: Adolescent; Adult; Aged; Aging; Alcohol Drinking; Cholesterol; Clofibrate; Dextrothyroxine; Diabetes Mellitus; Diet, Reducing; Gout; Halofenate; Humans; Hyperlipidemias; Male; Middle Aged; Obesity; Triglycerides | 1978 |
Recent progress in atherosclerosis research; experimental and clinical aspects.
Topics: Animals; Anticoagulants; Arteriosclerosis; Blood Platelets; Cell Division; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Endothelium; Humans; Lipoproteins; Neomycin; Nicotinic Acids; Platelet Adhesiveness; Platelet Aggregation; Thrombosis | 1978 |
[Current dietetic and pharmacological treatment of hyperlipoproteinemia].
Topics: Anion Exchange Resins; Clofibrate; Dextrothyroxine; Dietary Fats; Humans; Hyperlipidemias; Hypolipidemic Agents; Nicotinic Acids | 1975 |
Contemporary recommendations for evaluating and treating hyperlipidemia.
Topics: Clofibrate; Dextrothyroxine; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Lovastatin; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Phenotype; Probucol | 1986 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides | 1986 |
Drug interactions with coumarin anticoagulants. 2.
Topics: Allopurinol; Anabolic Agents; Animals; Anti-Bacterial Agents; Anticoagulants; Barbiturates; Chloral Hydrate; Chloramphenicol; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Coumarins; Dextrothyroxine; Diuretics; Drug Antagonism; Drug Synergism; Ethacrynic Acid; Ethanol; Glucagon; Glucocorticoids; Glutethimide; Humans; Oxyphenbutazone; Phenylbutazone; Quinidine; Quinine; Quinolines; Salicylates; Sulfinpyrazone; Sulfonamides; Thyroid Hormones; Tolbutamide | 1971 |
[Types of hyperlipoproteinemia, their relationship to atherosclerosis and treatment].
Topics: Arteriosclerosis; Cholesterol; Chylomicrons; Clofibrate; Densitometry; Dextrothyroxine; Diet Therapy; Estrogens; Heparin; Humans; Hyperlipidemias; Lipoproteins; Male; Nicotinic Acids; Triglycerides | 1972 |
Management of the hyperlipidemic patient.
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Estrogens; Humans; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism, Inborn Errors; Lipids; Metabolism, Inborn Errors; Nicotinic Acids; Triglycerides | 1973 |
Therapy of lipid disorders.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Diet Therapy; Drug Therapy, Combination; Female; Hospitals, Psychiatric; Humans; Hyperlipidemias; Male; Middle Aged; Neomycin; Nicotinic Acids; Sex Factors | 1973 |
Surgical treatment of hyperlipidemia. I. Apologia.
Topics: Arteriosclerosis; Bile; Cholesterol; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Drug Therapy, Combination; Follow-Up Studies; Humans; Hyperlipidemias; Ileum; Intestinal Absorption; Intestine, Small; Nicotinic Acids | 1974 |
Therapy of the hyperlipoproteinemias.
Topics: Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Norethindrone; Phenformin; Triglycerides | 1972 |
The treatment of hyperlipidemia.
Topics: Bile Acids and Salts; Cholesterol; Chylomicrons; Clofibrate; Dextrothyroxine; Diet Therapy; Fasting; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Triglycerides | 1971 |
[Hyperlipoproteinemia type II].
Topics: Adolescent; Adult; Cecum; Child; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Diet; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Ileum; Lipoproteins, LDL; Neomycin; Nicotinic Acids; Plasmapheresis; Portacaval Shunt, Surgical; Xanthogranuloma, Juvenile | 1980 |
Cholesterol reduction yields clinical benefit. A new look at old data.
Topics: Cholesterol; Cholesterol, Dietary; Clofibrate; Coronary Disease; Dextrothyroxine; Estrogens; Gemfibrozil; Humans; Hypercholesterolemia; Male | 1995 |
9 trial(s) available for dextrothyroxine and clofibrate
Article | Year |
---|---|
The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dextrothyroxine; Double-Blind Method; Estrogens; Humans; Male; Middle Aged; Myocardial Infarction; Nicotinic Acids; Prognosis; Time Factors; Triglycerides | 1977 |
The efficacy of lipid lowering drugs alone and in combination.
Topics: Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Dextrothyroxine; Drug Evaluation; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; Triglycerides | 1975 |
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.
Topics: Adult; Aspirin; Clofibrate; Dextrothyroxine; Estrogens; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Niacin; Time Factors | 1986 |
The Coronary Drug Project. Initial findings leading to modifications of its research protocol.
Topics: Adult; Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dextrothyroxine; Electrocardiography; Estrogens, Conjugated (USP); Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Nicotinic Acids; Placebos; Propionates; Pulmonary Embolism; Statistics as Topic; Thrombophlebitis; Time Factors | 1970 |
The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.
Topics: Adult; Cholesterol; Clofibrate; Coronary Disease; Dextrothyroxine; Electrocardiography; Estrogens, Conjugated (USP); Follow-Up Studies; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Nicotinic Acids; Placebos; Time Factors; Triglycerides | 1972 |
The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group.
Topics: Adult; Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dextrothyroxine; Drug Evaluation; Drug Therapy, Combination; Estrogens, Conjugated (USP); Follow-Up Studies; Humans; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Myocardial Infarction; Nicotinic Acids; Placebos; Recurrence; Sodium; Time Factors | 1973 |
The coronary drug project. Design, methods, and baseline results.
Topics: Adult; Alkaline Phosphatase; Anticholesteremic Agents; Bilirubin; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dextrothyroxine; Electrocardiography; Estrogens; Humans; Male; Methods; Middle Aged; Myocardial Infarction; Nicotinic Acids; Placebos; Research Design; Smoking; Triglycerides; United States; Uric Acid | 1973 |
Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
Topics: Adult; Aged; Angina Pectoris; Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Dextrothyroxine; Female; Humans; Male; Middle Aged; Placebos; Propionates | 1971 |
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone | 1983 |
32 other study(ies) available for dextrothyroxine and clofibrate
Article | Year |
---|---|
[Serum lipid-lowering drugs following myocardial infarction].
Topics: Cholesterol; Clofibrate; Dextrothyroxine; Estrogens, Conjugated (USP); Female; Germany, West; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Myocardial Infarction; Nicotinic Acids; Sex Factors; Triglycerides; United States | 1975 |
The Coronary Drug Project: implications for clinical care.
Topics: Clofibrate; Dextrothyroxine; Estrogens; Estrogens, Conjugated (USP); Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Nicotinic Acids; Prognosis; Smoking | 1977 |
Drug management of hypercholesterolemia.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hypercholesterolemia; Nicotinic Acids; Probucol; Sitosterols | 1979 |
Hypolipidemic drugs.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Probucol | 1978 |
[Drug treatment of primary hyperlipoproteinemia (author's transl)].
Topics: Anion Exchange Resins; Biguanides; Cholestyramine Resin; Clofibrate; Colestipol; DEAE-Dextran; Dextrothyroxine; Drug Therapy, Combination; Estrogens; Humans; Hyperlipidemias; Lipoproteins; Neomycin; Nicotinic Acids; Progestins; Sitosterols | 1978 |
Results of treatment of hyperlipidemias: long-term compliance and effect of lipid metabolism.
Topics: Bile Acids and Salts; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Lipid Mobilization; Lipoproteins; Nicotinic Acids; Time Factors | 1977 |
Arterial cholesterol esterase.
Topics: Animals; Aorta; Arteriosclerosis; Carboxylic Ester Hydrolases; Cholesterol Esters; Clofibrate; Dextrothyroxine; Dietary Fats; Hypolipidemic Agents; Nicotinic Acids; Oils; Sitosterols; Sterol Esterase | 1977 |
Dextrothyroxine for lowering cholesterol.
Topics: Angina Pectoris; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Humans; Hypercholesterolemia; Hyperlipidemias; Myocardial Infarction; Nicotinic Acids | 1976 |
Drug therapy of hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Drug Therapy, Combination; Humans; Hyperlipidemias; Nicotinic Acids; Sitosterols | 1976 |
[Treatment of hyperlipoproteinemia].
Topics: Adult; Clofibrate; Dextrothyroxine; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Neomycin; Nicotinic Acids | 1976 |
[Diet and drug therapy of hyperlipoproteinemia].
Topics: Butyrates; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dietary Fats; Humans; Hyperlipidemias; Hypolipidemic Agents; Neomycin; Nicotinic Acids | 1975 |
Drug treatment of hyperlipidemia.
Topics: Aminosalicylic Acids; Anabolic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Estrogens; Halofenate; Humans; Hyperlipidemias; Neomycin; Nicotinic Acids; Progesterone; Sitosterols | 1976 |
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; Coronary Disease; Dextrothyroxine; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Estrogens; Humans; Hypertension; Myocardial Infarction; Niacin; Sulfinpyrazone | 1985 |
Steinernema feltiae (= Neoaplectana carpocapsae): effect of sterols and hypolipidemic agents on development.
Topics: Animals; Anticholesteremic Agents; Caseins; Cholesterol; Cholestyramine Resin; Clofibrate; Culture Media; Dextrothyroxine; Female; Globulins; Hemin; Hydrogen-Ion Concentration; Male; Moths; Myoglobin; Nematoda; Niacin; Sterols | 1988 |
Rational drug therapy of the hyperlipoproteinemias, Part II.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol | 1986 |
Lipid-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Neomycin; Niacin; Pentanoic Acids; Probucol; Triglycerides | 1985 |
Xanthomas and hyperlipidemias.
Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Hypothyroidism; Kidney Diseases; Lipoproteins; Male; Neomycin; Niacin; Obesity; Pancreatitis; Xanthomatosis | 1985 |
Hyperlipoproteinemia. Some basic concepts on diagnosis and management.
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Blood Protein Disorders; Body Weight; Cholesterol; Chylomicrons; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Lipase; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Neomycin; Nicotinic Acids; Sodium; Triglycerides | 1973 |
[Treatment of hyperlipoproteinemias (author's transl)].
Topics: Adolescent; Adult; Anticholesteremic Agents; Child; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Ion Exchange Resins; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Metformin; Middle Aged; Nicotinic Acids; Phenformin | 1974 |
The hyperlipidaemias--a rational approach to classification and management.
Topics: Cholesterol; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hyperlipidemias; Nicotinic Acids; Triglycerides; Ultracentrifugation | 1972 |
Lipid lowering agents.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hyperlipidemias; Neomycin; Nicotinic Acids | 1972 |
The treatment of hyperlipidemia.
Topics: Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Estrogens; Humans; Hyperlipidemias; Nicotinic Acids; Progestins; Sitosterols | 1972 |
Classification of hyperlipidaemias.
Topics: Carbohydrate Metabolism; Cholestyramine Resin; Chylomicrons; Clofibrate; Dextrothyroxine; Diabetes Mellitus; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Metabolic Clearance Rate; Neomycin; Nicotinic Acids; Obesity; Oxymetholone; Triglycerides | 1971 |
Drug treatment of hyperlipidemia.
Topics: Cholestyramine Resin; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Nicotinic Acids | 1969 |
Treatment of the hyperlipidemic states with special emphasis on the place of cholestyramine in therapy.
Topics: Adolescent; Adult; Aged; Body Weight; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Electrophoresis; Fats, Unsaturated; Female; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Nicotinic Acids; Triglycerides | 1970 |
Diet and drugs in the treatment of hyperlipidemias.
Topics: Anticholesteremic Agents; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Propionates | 1970 |
Pharmacologic therapy for the hyperlipidemic patient.
Topics: Bile Acids and Salts; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Hypolipidemic Agents; Niacin; Probucol | 1983 |
[Lowering lipids rapidly and permanently with etofibrate].
Topics: Cholestyramine Resin; Clofibrate; Clofibric Acid; Dextrothyroxine; Humans; Hyperlipoproteinemias; Lipoproteins, HDL; Liver; Nicotinic Acids; Sitosterols | 1982 |
[Treatment of coronary heart disease with diet and lipid-reducing agents].
Topics: Adolescent; Adult; Child; Cholestyramine Resin; Clofibrate; Clofibric Acid; Colestipol; Coronary Disease; Dextrothyroxine; Humans; Hypolipidemic Agents; Nicotinic Acids; Risk | 1982 |
[Undesirable effects of hypolipemic drugs].
Topics: Adult; Arrhythmias, Cardiac; Avitaminosis; Biliary Tract Diseases; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Gastrointestinal Diseases; Gout; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Nicotinic Acids; Phospholipids; Pyridinolcarbamate; Sleep Initiation and Maintenance Disorders | 1980 |
[Indications for surgical treatment and medical treatment of atherosclerosis].
Topics: Arteriosclerosis; Aspirin; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dipyridamole; Humans; Hyperlipidemias; Hypolipidemic Agents; Intracranial Arteriosclerosis; Nicotinic Acids; Sitosterols; Sulfinpyrazone | 1980 |
THE SEPARATE HYPOLIPOPROTEINEMIC EFFECTS OF DEXTROTHYROXINE AND ETHYL CHLOROPHENOXYISOBUTYRATE.
Topics: Androsterone; Biomedical Research; Blood Chemical Analysis; Blood Proteins; Body Weight; Butyrates; Clofibrate; Dextrothyroxine; Hypercholesterolemia; Lipids; Lipoproteins; Pharmacology; Thyroxine; Triiodothyronine | 1964 |